- Home
- FBRX vs GRX Comparison
FBRX vs GRX Comparison
Compare FBRX & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- GRX
- Stock Information
- Founded
- FBRX N/A
- GRX 2007
- Country
- FBRX United States
- GRX United States
- Employees
- FBRX N/A
- GRX N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- GRX Finance/Investors Services
- Sector
- FBRX Health Care
- GRX Finance
- Exchange
- FBRX Nasdaq
- GRX Nasdaq
- Market Cap
- FBRX 125.9M
- GRX 151.1M
- IPO Year
- FBRX N/A
- GRX N/A
- Fundamental
- Price
- FBRX $15.35
- GRX $9.93
- Analyst Decision
- FBRX Strong Buy
- GRX
- Analyst Count
- FBRX 4
- GRX 0
- Target Price
- FBRX $77.58
- GRX N/A
- AVG Volume (30 Days)
- FBRX 61.1K
- GRX 39.7K
- Earning Date
- FBRX 11-14-2024
- GRX 01-01-0001
- Dividend Yield
- FBRX N/A
- GRX 5.98%
- EPS Growth
- FBRX N/A
- GRX N/A
- EPS
- FBRX N/A
- GRX 0.26
- Revenue
- FBRX N/A
- GRX N/A
- Revenue This Year
- FBRX N/A
- GRX N/A
- Revenue Next Year
- FBRX N/A
- GRX N/A
- P/E Ratio
- FBRX N/A
- GRX $38.50
- Revenue Growth
- FBRX N/A
- GRX N/A
- 52 Week Low
- FBRX $4.11
- GRX $7.73
- 52 Week High
- FBRX $28.68
- GRX $10.40
- Technical
- Relative Strength Index (RSI)
- FBRX 41.80
- GRX 57.01
- Support Level
- FBRX $14.66
- GRX $9.62
- Resistance Level
- FBRX $17.00
- GRX $9.99
- Average True Range (ATR)
- FBRX 2.62
- GRX 0.13
- MACD
- FBRX -0.86
- GRX 0.06
- Stochastic Oscillator
- FBRX 13.83
- GRX 95.46
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.